Cross-border mergers and acquisitions require careful planning under the best of circumstances. When international volatility enters the picture, including shifting trade policies, evolving antitrust regimes, and geopolitical uncertainty, the stakes rise significantly. U.S.-based companies pursuing a foreign acquisition must anticipate regulatory obstacles that did not exist even a few years ago, and adapt their deal strategy accordingly. Experienced transaction advisory support helps buyers translate that uncertainty into a defensible deal plan.
This article explains how international instability affects cross-border deals, which regulatory environments demand the closest attention, and what steps buyers can take to keep a foreign acquisition on track.
Why international volatility creates new risks for cross-border deals
Political and economic instability does not automatically prevent cross-border mergers and acquisitions from closing. However, volatility changes the regulatory landscape in ways that are difficult to predict. Governments under domestic pressure often tighten foreign investment screening, introduce new approval requirements, or extend review timelines, all of which can delay or derail a deal that would have proceeded smoothly in calmer conditions.
Currency fluctuations add another layer of complexity. A weakening local currency in the target’s country may make the acquisition appear more affordable on paper, but it can also signal deeper economic instability that increases post-close integration risk. Disciplined risk advisory work surfaces these macroeconomic exposures before they reach the balance sheet. Buyers who focus only on the purchase price without evaluating the broader macroeconomic environment may inherit operational challenges they did not anticipate.
Trade tensions between major economies also affect cross-border deals in subtle ways. Tariff disputes, sanctions regimes, and export controls can change the strategic rationale for an acquisition after the letter of intent has been signed. Companies need to stress-test their deal thesis against plausible geopolitical scenarios, not just current conditions.
How the global merger enforcement landscape is shifting
The regulatory framework governing cross-border mergers and acquisitions looks fundamentally different today than it did a decade ago. Several key jurisdictions have expanded their enforcement capabilities, and more changes are likely on the horizon.
European Union antitrust enforcement
The European Union has built a reputation for aggressive antitrust enforcement, particularly in technology and digital markets. Under the EU merger control regime, the European Commission has shown a willingness to block deals, impose substantial fines, and require significant divestitures as conditions of approval. For U.S. companies pursuing a cross-border acquisition with a European target, this means preparing for a longer and more demanding review process than they might face domestically.
EU regulators are especially focused on deals they believe could create or strengthen a dominant market position. Even acquisitions that receive approval from U.S. authorities may face objections in Brussels. Companies should factor this regulatory asymmetry into their deal timeline and negotiation strategy from the outset.
China’s evolving review process
China’s Ministry of Commerce, and more recently the State Administration for Market Regulation (SAMR), has become an increasingly influential gatekeeper for international M&A transactions. What was once a relatively light regulatory environment has transformed into a process that can involve extensive documentation requests, prolonged review periods, and unpredictable decision-making.
Transparency remains a concern. Unlike Western regulators, Chinese authorities do not always publish detailed reasoning behind their decisions, making it difficult for deal teams to anticipate objections or tailor their submissions effectively. Companies planning a foreign acquisition with any connection to the Chinese market should engage local regulatory counsel early in the process.
Post-Brexit regulatory divergence in the United Kingdom
Since leaving the European Union, the United Kingdom has established its own Competition and Markets Authority (CMA) as an independent merger review body. The CMA has quickly demonstrated a willingness to take positions that differ from both the EU and U.S. regulators, including blocking deals that other jurisdictions approved.
For cross-border deals involving UK operations or customers, this means a separate and potentially conflicting regulatory review process. Buyers must now manage three distinct enforcement regimes, U.S., EU, and UK, rather than two, which adds both cost and timeline risk.
What every buyer should do before pursuing a foreign acquisition
Preparation is the most effective defense against volatility-driven disruption in cross-border mergers and acquisitions. Companies that invest in regulatory intelligence and local expertise before signing a deal are far less likely to encounter surprises that delay closing or destroy value.
Identify every relevant regulatory authority
A foreign acquisition triggers regulatory review not only in the target’s home country but potentially in every jurisdiction where the target has a meaningful business presence. Buyers must map the full regulatory landscape before committing to a deal, including jurisdictions where revenue or employee counts may seem small but still cross filing thresholds.
This mapping exercise should cover antitrust and competition authorities, foreign investment screening bodies, industry-specific regulators, and any national security review processes. Missing a single filing requirement can create delays that undermine deal momentum and give competitors an opening.
Engage local advisors with regulatory relationships
Executing a cross-border acquisition successfully requires more than legal expertise. It requires relationships and cultural fluency in the target’s regulatory environment. Companies should consider hiring local counsel, investment bankers, or advisory firms with a track record of obtaining approval for deals involving U.S. buyers.
Local advisors provide several advantages that remote counsel cannot replicate. They understand informal communication norms with regulatory officials. They can anticipate the types of remedies or divestitures that authorities are likely to require. And they can provide realistic estimates of how long the approval process will take, which is critical for managing deal certainty and financing commitments.
Build regulatory risk into deal structure and timeline
The purchase agreement itself should reflect the realities of cross-border regulatory approval. Buyers should negotiate adequate outside dates that account for multi-jurisdictional reviews, include clear conditions precedent for regulatory clearances, and establish termination fee structures that protect both parties if approval is denied or delayed beyond a reasonable period.
Deal teams that treat regulatory approval as a formality rather than a genuine risk factor are setting themselves up for costly surprises. In a volatile international environment, the regulatory workstream deserves the same level of attention and resourcing as financial due diligence.
How to avoid common deal-killing mistakes during volatile periods
Cross-border mergers and acquisitions are challenging enough during periods of relative stability. When regulatory regimes are shifting simultaneously across multiple jurisdictions, the margin for error shrinks dramatically. Three mistakes account for most deal failures in this environment.
First, underestimating the timeline for multi-jurisdictional review. Each additional regulatory authority adds weeks or months to the approval process, and these reviews rarely run in parallel without careful coordination. Buyers who set aggressive closing dates without accounting for regulatory sequencing often find themselves requesting extensions or watching deal economics deteriorate.
Second, failing to anticipate remedies. Regulators in different jurisdictions may require different, and potentially conflicting, divestitures or behavioral commitments as conditions of approval. Buyers should model potential remedy scenarios during due diligence rather than waiting for regulators to dictate terms.
Third, neglecting political risk assessment. In volatile environments, regulatory decisions can be influenced by political considerations that have nothing to do with competition law. A cross-border deal that becomes politically sensitive, whether because of the industry, the target’s role in the local economy, or the buyer’s country of origin, may face obstacles that no amount of legal preparation can overcome. Political risk analysis should be a standard component of due diligence for any international M&A transaction.
Frequently Asked Questions
How does international volatility affect cross-border mergers and acquisitions?
International volatility increases regulatory unpredictability, extends approval timelines, and introduces new screening requirements for foreign buyers. Governments facing domestic instability often tighten foreign investment rules, which can delay or block deals that would have closed without issue in stable conditions. Currency fluctuations and trade disputes add further uncertainty to deal economics and post-close integration planning.
What regulatory bodies must approve a foreign acquisition?
Every jurisdiction where the target company has a meaningful business presence may require regulatory approval. This typically includes antitrust authorities, foreign investment screening bodies, and industry-specific regulators in the target’s home country. Some jurisdictions also conduct national security reviews that apply to foreign buyers regardless of the industry involved.
Why is the EU more aggressive on cross-border M&A enforcement?
The European Commission applies a rigorous standard when evaluating whether a deal could create or strengthen a dominant market position. EU regulators have historically been willing to block transactions or require significant divestitures even when U.S. authorities approve the same deal. This reflects a different philosophical approach to competition law that prioritizes market structure over consumer welfare arguments.
How has China’s approach to merger review changed?
China’s regulatory approach has shifted dramatically over the past decade. Where foreign acquisitions once faced minimal scrutiny, SAMR now conducts detailed reviews that can involve extensive documentation requests and prolonged timelines. Decision-making transparency remains limited, making it difficult for deal teams to predict outcomes or tailor their regulatory strategy effectively.
What role do local advisors play in cross-border acquisitions?
Local advisors provide regulatory relationships, cultural fluency, and practical knowledge that remote counsel cannot replicate. They help buyers navigate informal communication norms with regulatory officials, anticipate likely remedy requirements, and set realistic expectations for approval timelines. Engaging experienced local counsel early in the process significantly reduces the risk of regulatory surprises.
Can political instability actually block a cross-border deal?
Political instability can create conditions that effectively block a deal even without a formal regulatory rejection. Governments may impose new foreign investment restrictions, delay review processes indefinitely, or attach conditions that make the deal economically unviable. Buyers should conduct political risk assessments as a standard part of due diligence for any cross-border acquisition in a volatile environment.
